Physicians' Academy for Cardiovascular Education

Alirocumab Treatment Effect Did Not Differ Between Patients With and Without Low HDL-C or High Triglyceride Levels in Phase 3 trials

June 19, 2015

Presentation prepared and held by Dr Kees Hovingh (AMC Amsterdam) in Clinical Breakthroughs session: Modifying LDL cholesterol to prevent CV events, Tuesday, May 26, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images

Alirocumab Treatment Effect Did Not Differ Between Patients.pdf (0,7MB)Alirocumab Treatment Effect Did Not Differ Between Patients.pdf (0,7MB)